VIR logo

VIR

Vir Biotechnology Inc.

$6.70
+$0.15(+2.29%)
60
Overall
60
Value
72
Tech
50
Quality
Market Cap
$720.67M
Volume
856.18K
52W Range
$4.16 - $14.45
Target Price
$17.22

Latest News for VIR

Virco Manufacturing Reports Q3 Loss Amid Market Challenges
TipRanks Auto-Generated Newsdesk3 days agoDec 09, 2025

Virco Manufacturing ( ($VIRC) ) has released its Q3 earnings. Here is a breakdown of the information Virco Manufacturing presented to its investors......

Virco Manufacturing Reports Q3 2025 Net Loss
TipRanks Auto-Generated Newsdesk3 days agoDec 08, 2025

Virco Manufacturing ( ($VIRC) ) just unveiled an update. Virco Mfg. Corporation reported a net loss of $1.3 million for the third quarter of 2025, ......

Medivir AB Secures SEK 151 Million Through Rights Issue
TipRanks Sweden Auto-Generated Newsdesk8 days agoDec 03, 2025

An announcement from Medivir AB ( ($SE:MVIR) ) is now available. Medivir AB announced the results of its fully guaranteed rights issue, raising app......

H.C. Wainwright Keeps Their Buy Rating on Vir Biotechnology (VIR)
TipRanks Auto-Generated Intelligence Newsdesk20 days agoNov 21, 2025

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Vir Biotechnology yesterday and set a price target of $15.00. According to TipR......

Kepler Capital Keeps Their Buy Rating on Viridien (0RI9)
TipRanks Auto-Generated Intelligence Newsdesk21 days agoNov 21, 2025

Kepler Capital analyst Kevin Roger maintained a Buy rating on Viridien on November 19 and set a price target of €160.00. The company’s shares close......

Viridien (0RI9) Receives a Buy from Kepler Capital
TipRanks Auto-Generated Intelligence Newsdeska month agoNov 15, 2025

In a report released on November 13, Kevin Roger from Kepler Capital maintained a Buy rating on Viridien, with a price target of €160.00. The compa......

Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX) and Atea Pharmaceuticals (AVIR)
Brian Andersona month agoNov 12, 2025

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenax Therapeutics (TENX – Research Report) and Atea......

Barclays Sticks to Their Buy Rating for Vir Biotechnology (VIR)
TipRanks Auto-Generated Intelligence Newsdeska month agoNov 12, 2025

Barclays analyst Gena Wang maintained a Buy rating on Vir Biotechnology yesterday and set a price target of $31.00. The company’s shares closed yes......

News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.

ABCD
1SymbolPriceChangeVol
2VIR$6.70+2.3%856.18K
3
4
5
6

Get Vir Biotechnology Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.